Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

512 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Detection of soluble interleukin-2 receptor and interleukin-10 in the serum of patients with aggressive non-Hodgkin's lymphoma. Identification of a subset at high risk of treatment failure.
Stasi R, Zinzani L, Galieni P, Lauta VM, Damasio E, Dispensa E, Dammacco F, Tura S, Papa G. Stasi R, et al. Among authors: dammacco f. Cancer. 1994 Sep 15;74(6):1792-800. doi: 10.1002/1097-0142(19940915)74:6<1792::aid-cncr2820740623>3.0.co;2-f. Cancer. 1994. PMID: 8082082
Alpha-2b recombinant interferon (Intron-A) as maintenance treatment in multiple myeloma.
Avvisati G, Petrucci MT, Pulsoni A, Tribalto M, Lauta VM, Gernone A, Boccadoro M, Marmont F, Pileri A, Dammacco F, et al. Avvisati G, et al. Among authors: dammacco f. Eur J Haematol Suppl. 1990;52:9-11. doi: 10.1111/j.1600-0609.1990.tb00897.x. Eur J Haematol Suppl. 1990. PMID: 2279547 Clinical Trial. No abstract available.
CEOP-B/VIMB vs. promace-CytaBOM in the treatment of intermediate or high grade non-Hodgkin's lymphoma: A randomised multicenter study of Southern Italy Cooperative Group.
Lorusso V, Palmieri G, Bianco AR, Abate G, Catalano G, De Vita F, Dammacco F, Lauta VM, Lucarelli G, Polimeno G, Mantovani G, D'Aprile M, Marzullo F, De Lena M. Lorusso V, et al. Among authors: dammacco f. Int J Oncol. 2000 Jan;16(1):149-54. doi: 10.3892/ijo.16.1.149. Int J Oncol. 2000. PMID: 10601560 Clinical Trial.
Short term treatment with Escherichia coli recombinant human granulocyte-macrophage-colony stimulating factor prior to chemotherapy for Hodgkin disease.
Aglietta M, Montemurro F, Fagioli F, Volta C, Botto B, Cantonetti M, Racanelli V, Teofili L, Ferrara R, Amadori S, Castoldi GL, Dammacco F, Levis A. Aglietta M, et al. Among authors: dammacco f. Cancer. 2000 Jan 15;88(2):454-60. doi: 10.1002/(sici)1097-0142(20000115)88:2<454::aid-cncr28>3.0.co;2-q. Cancer. 2000. PMID: 10640980 Clinical Trial.
512 results